Reach-Through Rights in Biomedical Patent Licensing: A Comparative Analysis of their Anti-Competitive Reach

Medical biotechnology offers vast opportunity for the treatment of human genetic conditions, including the development and improvement of drugs, diagnostic capabilities and therapeutic techniques. Australian health and medical research has a rich and proud history. This has been recognised in numerous federal government reports, which examine the sustainability of research momentum and the ability of the Australian industry to capitalise on this research base. Australia's increasing $1 billion trade deficit in pharmaceuticals, medical equipment and other health and medical industries has been a major impetus for the push to develop Australia's medical research base.